dc.creator | Heesom, Lesley | |
dc.creator | Rehnberg, Lucas | |
dc.creator | Nasim-Mohi, Myra | |
dc.creator | Jackson, Alexander I.R. | |
dc.creator | Celinski, Michael | |
dc.creator | Dushianthan, Ahilanadan | |
dc.creator | Cook, Paul | |
dc.creator | Rivinberg, William | |
dc.creator | Saeed, Kordo | |
dc.date.accessioned | 2020-09-30T21:39:31Z | |
dc.date.accessioned | 2022-09-23T18:16:23Z | |
dc.date.available | 2020-09-30T21:39:31Z | |
dc.date.available | 2022-09-23T18:16:23Z | |
dc.date.created | 2020-09-30T21:39:31Z | |
dc.identifier | 2213-7165 | |
dc.identifier | http://dx.doi.org/10.1016/j.jgar.2020.07.017 | |
dc.identifier | http://hdl.handle.net/20.500.12010/14055 | |
dc.identifier | http://dx.doi.org/10.1016/j.jgar.2020.07.017 | |
dc.identifier.uri | http://repositorioslatinoamericanos.uchile.cl/handle/2250/3498302 | |
dc.description.abstract | The coronavirus-2019 (COVID-19) pandemic caused by the
virus SARS-CoV-2 infection has imposed significant demand on all
healthcare systems. Based on national and international guidance
which were mostly anecdotal [1], COVID-19 patients admitted to
our General Intensive Care Unit (GICU) were routinely commenced
on antibiotics to cover possible secondary bacterial lower
respiratory tract infection (LRTI). The antibiotics should have been
reviewed after 48 h, however, it was challenging to stop early
because of the many factors such as persistent hyperinflammatory
status, ongoing/worsening lung infiltrates with the need for
continued mechanical ventilation, and also partly because of the
lack of reliable indicators of bacterial infection. | |
dc.language | eng | |
dc.publisher | Journal of Global Antimicrobial Resistance | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.rights | Abierto (Texto Completo) | |
dc.source | reponame:Expeditio Repositorio Institucional UJTL | |
dc.source | instname:Universidad de Bogotá Jorge Tadeo Lozano | |
dc.subject | COVID-19 | |
dc.subject | SARS-CoV-2 | |
dc.subject | Procalcitonin | |
dc.subject | PCT | |
dc.subject | Antibiotic stewardship | |
dc.title | Procalcitonin as an antibiotic stewardship tool in COVID-19 patients in the intensive care unit | |